Exploring Long-term Risks and STI Prevalence in Pre-Exposure Prophylaxis Users in Gironde, France

Launched by UNIVERSITY HOSPITAL, BORDEAUX · Sep 12, 2024

Keywords

ClinConnect Summary

The SAFER-PrEP clinical trial is looking at how long-term use of Pre-Exposure Prophylaxis (PrEP) affects sexual behaviors and the rates of Sexually Transmitted Infections (STIs) among users in the Gironde region of France. The researchers want to compare the STI rates between people who have been using PrEP for more than a year and those who have been on it for less than a year. This study will help us understand how sexual health practices may change over time and could lead to better strategies for preventing HIV and STIs in the future.

To participate in this study, individuals must be over 18 years old, have been using PrEP for at least six months, be able to speak French, and be affiliated with health insurance. Unfortunately, individuals who are already known to be HIV positive cannot take part. Participants will be asked to share their experiences related to their PrEP use and sexual health, and they will need to provide consent to join the study. This research is still recruiting participants, and everyone’s input can help improve sexual health support for others.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Aged over 18 years old;
• • Participants using PrEP for at least 6 months ;
• • French-speaking, without comprehension disorders ;
• • being affiliated to health insurance ;
• • Willing to participate and to sign informed consent.
• Exclusion Criteria:
• • Individuals with known HIV positivity;